当前位置:首页 - 行情中心 - 智飞生物(300122) - 财务分析

智飞生物

(300122)

  

流通市值:492.60亿  总市值:833.76亿
流通股本:14.14亿   总股本:23.94亿

智飞生物(300122)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润14.58亿元,每股收益0.61元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益3266379.49万元,未分配利润2931586.03万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产5356880.08万元,负债2090500.60万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入11,395,682,504.7152,917,767,029.239,271,716,845.2124,445,313,338.85
营业总成本9,323,352,619.2643,094,356,363.4331,146,168,101.4619,160,755,294.29
营业利润1,736,662,374.469,373,439,535.357,635,847,800.024,967,447,560.2
利润总额1,733,765,069.359,342,293,287.687,619,073,617.384,962,334,956.4
净利润1,457,744,248.178,069,868,204.156,530,323,266.834,259,927,399.09
其他综合收益----
综合收益总额1,457,744,248.178,069,868,204.156,530,323,266.834,259,927,399.09
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计45,731,274,065.942,514,016,731.0642,066,348,094.4840,907,529,076.65
非流动资产合计7,837,526,782.977,718,173,583.297,205,819,062.326,952,981,566.16
资产总计53,568,800,848.8750,232,190,314.3549,272,167,156.847,860,510,642.81
流动负债合计20,211,954,471.5318,086,487,010.418,638,843,279.6819,489,439,559.41
非流动负债合计693,051,487.98639,622,490.63666,788,001.12674,931,075.14
负债合计20,905,005,959.5118,726,109,501.0319,305,631,280.820,164,370,634.55
归属于母公司股东权益合计32,663,794,889.3631,506,080,813.3229,966,535,87627,696,140,008.26
股东权益合计32,663,794,889.3631,506,080,813.3229,966,535,87627,696,140,008.26
负债和股东权益合计53,568,800,848.8750,232,190,314.3549,272,167,156.847,860,510,642.81
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计8,387,064,252.2848,064,340,214.7532,084,245,278.619,671,449,821.95
经营活动现金流出小计12,660,740,852.0339,067,970,233.6229,498,411,777.617,494,401,510.4
经营活动产生的现金流量净额-4,273,676,599.758,996,369,981.132,585,833,5012,177,048,311.55
投资活动现金流入小计23,000168,073,400.86150,370,264.32759,175
投资活动现金流出小计236,232,912.391,144,672,122.45819,695,003.79562,560,265.11
投资活动产生的现金流量净额-236,209,912.39-976,598,721.59-669,324,739.47-561,801,090.11
筹资活动现金流入小计4,097,486,1526,347,985,763.876,122,796,383.093,128,359,293.09
筹资活动现金流出小计2,956,497,313.3210,641,852,590.697,754,136,750.453,988,930,569.79
筹资活动产生的现金流量净额1,140,988,838.68-4,293,866,826.82-1,631,340,367.36-860,571,276.7
汇率变动对现金及现金等价物的影响161,585.67-2,303,049.15-1,008,716.81-354,047.57
现金及现金等价物净增加额-3,368,736,087.793,723,601,383.57284,159,677.36754,321,897.17
期末现金及现金等价物余额2,970,554,147.126,339,290,234.912,899,848,528.73,370,010,748.51
最新报告期:2024-04-25
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
国盛证券张金洋,胡偌碧3.994.815.682024-04-25
国盛证券张金洋3.835.016.262024-02-23
国盛证券张金洋,胡偌碧3.835.016.252024-02-23
中金公司张琎,杨一正3.634.625.452024-02-19
中金公司张琎,朱言音,杨一正4.625.45--2024-02-19
TOP↑